Prices delayed by at least 15 minutes | Print


Azenta (AZTA)

Common Shares
Sell: $20.48|Buy: $66.41|Change: 0.91 (-1.73%)

Open 

$52.55


Previous close 

$52.51


Trade high 

$53.51


Volume 

588,713


Year high 

$69.16


Year low 

$36.01


Dividend yield 

-


Market capitalisation 

$2.82 bn


P/E ratio 

71.94


ISIN 

US1143401024


This share can be held in a Dealing accountISALifetime ISAJISASIPP

Share price

Dividends

PreviousLatest
Record date03/09/202103/12/2021
Ex-dividend date02/09/202102/12/2021
Payment date24/09/202123/12/2021
Amount$0.1$0.1

Performance 10/05/2024

1D | 1M | 3M | 1Y | 3Y ann | 5Y ann | 10Y ann


Total return (%)
Azenta- 1.73
More...

Company profile

Azenta Inc is a provider of life sciences solutions, enabling impactful breakthroughs and therapies to market faster. It provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. The company has two reportable segments that are Life Sciences Products and Life Sciences Services. It generates a substantial part of its revenue from its Life Sciences Services segment.

Sector 

Healthcare


AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2024 AJ Bell. All rights reserved.